Author

Nina S. Kadan‐Lottick

Georgetown UniversityORCID 0000-0002-6857-396XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Anna M. JermakowicziD· 1 shared Derek J. HansoniD· 1 shared Jonathan ChuiD· 1 shared Luz Clarita RuiziD· 1 shared Nagi G. AyadiD· 1 shared Nitish JangdeiD· 1 shared Robert K. SuteriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna M. JermakowiczORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients

Anna M. Jermakowicz, Luz Clarita Ruiz, Jonathan Chu, Nitish Jangde, Robert K. Suter, Nina S. Kadan‐Lottick, Derek J. Hanson, Nagi G. Ayad

This paper develops DrugSeq, a computational platform that predicts drug sensitivities in medulloblastoma subgroups, identifying subgroup-specific therapies and potential drug repositioning candidates.

Scientific Reports · Nov 27, 2025Peer-reviewedCancer Biology